EUVIMEDEUVIMED entdecken
Crossref

Inhibition of nucleation and disruption of amyloid fibrillation in human lysozyme aggregation by a potent Cu(II) flufenamate chemotherapeutic drug candidate

Huzaifa Yasir Khan, Yassir Hasan Khan, Md Nadir Hassan, Azeem Ahmad, Rizwan Hasan Khan, Farukh Arjmand

Biophysical Chemistry · 2025

DOI: 10.1016/j.bpc.2025.107493 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biophysical Chemistry, 2025. Verfasst von Huzaifa Yasir Khan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, UP, India; Department of Chemistry, Aligarh Muslim University, Aligarh 2020…. Hauptthemen laut MEDLINE: Muramidase, Amyloid, Copper, Protein Aggregates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Indian Council of Medical Research, Aligarh Muslim University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MuramidaseAmyloidCopperProtein AggregatesAntineoplastic AgentsCoordination ComplexesHumans

Stichwörter der Autor:innen

Biophysical studiesCu(II) complexHuman lysozyme fibrillationPrimary nucleationSecondary nucleation

Substanzen

MuramidaseAmyloidCopperProtein AggregatesAntineoplastic AgentsCoordination Complexes

Autor:innen und Institutionen

  • Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, UP, India; Department of Chemistry, Aligarh Muslim University, Aligarh 202002, UP, India.
  • Department of Zoology, Aligarh Muslim University Aligarh, UP, India.
  • Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, UP, India.
  • Department of Chemistry, Aligarh Muslim University, Aligarh 202002, UP, India. Electronic address: farukh.arjmand18@gmail.com.

Förderung

  • Indian Council of Medical Research
  • Aligarh Muslim University

Zitieren

APA

Khan, H. Y., Khan, Y. H., Hassan, M. N., Ahmad, A., Khan, R. H., & Arjmand, F. (2025). Inhibition of nucleation and disruption of amyloid fibrillation in human lysozyme aggregation by a potent Cu(II) flufenamate chemotherapeutic drug candidate. Biophysical Chemistry. https://doi.org/10.1016/j.bpc.2025.107493

Vancouver

Khan HY, Khan YH, Hassan MN, Ahmad A, Khan RH, Arjmand F. Inhibition of nucleation and disruption of amyloid fibrillation in human lysozyme aggregation by a potent Cu(II) flufenamate chemotherapeutic drug candidate. Biophysical Chemistry. 2025. doi:10.1016/j.bpc.2025.107493

BibTeX
@article{Khan2025,
  author = {Khan, Huzaifa Yasir and Khan, Yassir Hasan and Hassan, Md Nadir and Ahmad, Azeem and Khan, Rizwan Hasan and Arjmand, Farukh},
  title = {Inhibition of nucleation and disruption of amyloid fibrillation in human lysozyme aggregation by a potent Cu(II) flufenamate chemotherapeutic drug candidate},
  journal = {Biophysical Chemistry},
  year = {2025},
  doi = {10.1016/j.bpc.2025.107493}
}
Kostenlos starten →